XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis ; volume:10 ; number:6 ; day:21 ; month:5 ; year:2019 ; pages:1-14 ; date:6.2019
Cell death & disease ; 10, Heft 6 (21.5.2019), 1-14, 6.2019
- Creator
-
Zhu, Zhi-Chuan
Liu, Ji-Wei
Yang, Can
Zhao, Miao
Xiong, Zhi-Qi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-019-1627-9
- URN
-
urn:nbn:de:101:1-2019102209495592592046
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhu, Zhi-Chuan
- Liu, Ji-Wei
- Yang, Can
- Zhao, Miao
- Xiong, Zhi-Qi
- SpringerLink (Online service)
Other Objects (12)
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
Synthesis of a Macrocyclic Mcl-1 Inhibitor
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
Der Apoptosis-Inhibitor Bcl-xl in neuronalem Zelltod und der Alzheimer-Krankheit
Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model
Small‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
Synthesis of a Macrocyclic Mcl-1 Inhibitor
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
Der Apoptosis-Inhibitor Bcl-xl in neuronalem Zelltod und der Alzheimer-Krankheit
Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model
Small‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
Synthesis of a Macrocyclic Mcl-1 Inhibitor
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Targeting antiapoptotic proteins Bcl-xL and Mcl-1 in cholangiocarcinoma
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
Der Apoptosis-Inhibitor Bcl-xl in neuronalem Zelltod und der Alzheimer-Krankheit
Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model